Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY) PT Lowered to Rs5,110 at Goldman Sachs, Following Earnings

July 27, 2021 3:10 PM EDT
Get Alerts RDY Hot Sheet
Price: $64.87 -0.28%

Rating Summary:
    8 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 5 | New: 36
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Goldman Sachs analyst Shyam Srinivasan lowered the price target on Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (NYSE: RDY) to Rs5,110.00 (from Rs5,280.00) while maintaining a Neutral rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Intl Ratings

Related Entities

Goldman Sachs, Earnings